Catalyst Pharmaceuticals
CPRX
$40.02
Share price
-2.22%
Change (1 day)
66.14%
Change (1 year)
Categories
Earnings for Catalyst Pharmaceuticals (CPRX)
Earnings in 2024 (TTM): A$0.32 Billion
According to Catalyst Pharmaceuticals's latest financial reports the company's current earnings are A$0.49 Billion. , an increase over its 2023 earnings that were of A$0.15 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Catalyst Pharmaceuticals from 2007 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | A$0.34 B | 128.82% |
| 2023 | A$0.15 B | -9.75% |
| 2022 | A$0.16 B | 98.83% |
| 2021 | A$83.79 M | 25.73% |
| 2020 | A$66.65 M | 25.38% |
| 2019 | A$53.15 M | -198.25% |
| 2018 | -A$54.11 Million | 84.68% |
| 2017 | -A$29.3 Million | 1.88% |
| 2016 | -A$28.76 Million | -10.68% |
| 2015 | -A$32.2 Million | 30.46% |
| 2014 | -A$24.68 Million | 27.6% |
| 2013 | -A$19.34 Million | 198.17% |
| 2012 | -A$6.49 Million | -36.22% |
| 2011 | -A$10.17 Million | 59.52% |
| 2010 | -A$6.38 Million | -44.68% |
| 2009 | -A$11.53 Million | -31.45% |
| 2008 | -A$16.81 Million | 155.21% |
| 2007 | -A$6.59 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | A$0.86 B | 150.51% | 🇺🇸 USA |
 | A$0.41 B | 20.58% | 🇺🇸 USA |
 | A$27.75 B | 7,965.18% | 🇺🇸 USA |
 | -A$0.44 Billion | -225.67% | 🇺🇸 USA |
 | A$17.68 B | 5,038.65% | 🇺🇸 USA |
 | A$11.15 B | 3,142.81% | 🇺🇸 USA |